{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:31:30Z","timestamp":1793968290630,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIA BC 012066"],"award-info":[{"award-number":["ZIA BC 012066"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcyt.2026.102980","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:15:34Z","timestamp":1786202134000},"page":"102980","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia during GPC2-CAR T-cell manufacturing compromises cell expansion and cytotoxic capacity"],"prefix":"10.1016","volume":"28","author":[{"given":"Ira","family":"Phadke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-691X","authenticated-orcid":false,"given":"Ryan A.","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3403-6824","authenticated-orcid":false,"given":"Zoe","family":"Schmiechen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah W.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.","family":"Shern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Prochazkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangsuk","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Highfill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5143-2055","authenticated-orcid":false,"given":"Rosa","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcyt.2026.102980_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101171","article-title":"Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and \u03b3\u03b4 T cell output","volume":"32","author":"Song","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102980_bib0002","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","article-title":"IL15 enhances CAR-T cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype","volume":"7","author":"Alizadeh","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102980_bib0003","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/2326-6066.CIR-15-0009","article-title":"The shared and contrasting roles of IL2 and IL15 in the life and death of normal and neoplastic lymphocytes: implications for cancer therapy","volume":"3","author":"Waldmann","year":"2015","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102980_bib0004","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jcyt.2024.03.003","article-title":"CAR-T cell expansion platforms yield distinct T cell differentiation states","volume":"26","author":"Song","year":"2024","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102980_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.09.013","article-title":"Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies","volume":"28","author":"Dreyzin","year":"2026","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102980_bib0006","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1016\/j.cell.2026.03.047","article-title":"Distinct in vivo dynamics of donor-derived stem cell memory CAR T cells post-allogeneic HSCT relapse","volume":"189","author":"Gattinoni","year":"2026","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.jcyt.2026.102980_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj2820","article-title":"Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL","volume":"8","author":"Bai","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102980_bib0008","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.jcyt.2026.102980_bib0009","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00723-021-01383-6","article-title":"Oxygenation status of malignant tumors vs. normal tissues: critical evaluation and updated data source based on direct measurements with pO2 microsensors","volume":"52","author":"Vaupel","year":"2021","journal-title":"Appl Magn Reson"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102980_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41590-022-01379-9","article-title":"Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity","volume":"24","author":"Vignali","year":"2023","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2026.102980_bib0011","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat Immunol"},{"issue":"3","key":"10.1016\/j.jcyt.2026.102980_bib0012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccell.2017.08.003","article-title":"Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma","volume":"32","author":"Bosse","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102980_bib0013","article-title":"CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice","volume":"2","author":"Li","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102980_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005881","article-title":"Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma","volume":"11","author":"Sun","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102980_bib0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1158\/2326-6066.CIR-24-0975","article-title":"GPC2-targeted CAR T cells engineered with NFAT-inducible membrane-tethered IL15\/IL21 exhibit enhanced activity against neuroblastoma","volume":"13","author":"Okada","year":"2025","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"10.1016\/j.jcyt.2026.102980_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100942","article-title":"Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models","volume":"2","author":"Li","year":"2021","journal-title":"STAR Protoc"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102980_bib0017","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1158\/1535-7163.MCT-06-0145","article-title":"Chronic hypoxia promotes hypoxia-inducible factor-1\u03b1\u2013dependent resistance to etoposide and vincristine in neuroblastoma cells","volume":"5","author":"Hussein","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102980_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010039","article-title":"Hypoxia in the initiation and progression of neuroblastoma tumours","volume":"21","author":"Huertas-Casta\u00f1o","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jcyt.2026.102980_bib0019","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","article-title":"Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype","volume":"10","author":"Holmquist-Mengelbier","year":"2006","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.jcyt.2026.102980_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092343","article-title":"Hypoxia predicts poor prognosis in neuroblastoma patients and associates with biological mechanisms involved in telomerase activation and tumor microenvironment reprogramming","volume":"12","author":"Cangelosi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"24","key":"10.1016\/j.jcyt.2026.102980_bib0021","doi-asserted-by":"crossref","first-page":"10351","DOI":"10.1158\/0008-5472.CAN-10-0740","article-title":"Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha","volume":"70","author":"Qing","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.jcyt.2026.102980_bib0022","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ng.3899","article-title":"Neuroblastoma is composed of two super-enhancer-associated differentiation states","volume":"49","author":"van Groningen","year":"2017","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jcyt.2026.102980_bib0023","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41467-019-09470-w","article-title":"A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma","volume":"10","author":"van Groningen","year":"2019","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102980_bib0024","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/2159-8290.CD-24-0046","article-title":"Identification and characterization of chemotherapy-resistant high-risk neuroblastoma persister cells","volume":"14","author":"Grossmann","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jcyt.2026.102980_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675786","article-title":"Production of functional CD19 CAR T cells under hypoxic manufacturing conditions","volume":"16","author":"Micallef Nilsson","year":"2025","journal-title":"Front Immunol"},{"issue":"5, Supplement","key":"10.1016\/j.jcyt.2026.102980_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.03.381","article-title":"Culturing T cells under hypoxic and hyperbaric conditions yields increased proliferation and functional potency without changes in phenotype","volume":"27","author":"Massi","year":"2025","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.jcyt.2026.102980_bib0027","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:23:10Z","timestamp":1793967790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926009412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1465324926009412"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102980","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoxia during GPC2-CAR T-cell manufacturing compromises cell expansion and cytotoxic capacity","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102980"}}